WVE-007 Shows Muscle-Preserving Fat Loss in Early Data, But Weight Reduction Remains Modest

Wave Life Sciences' WVE-007 (INHBE-targeted) showed ~5% total fat reduction and 14% visceral fat drop with muscle preserved after one dose. Early results are modest (1% weight loss), but support infrequent dosing as potential GLP-1 complement.